MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    CB2R agonist AM1241 reverses the development of MPTP-induced PD and activates the regeneration of DA neurons

    R. Zhu (Shanghai, China)

    Objective: A promising and potential direction to treat PD is to develop new non-dopaminergic drugs without producing dyskinesia, as well as arresting and even reversing…
  • 2017 International Congress

    Pairing TMS and physical therapy for treatment of gait and balance disorders in Parkinson’s Disease: a randomized pilot trial

    A. Cucca, H. Migdadi, T. Biller, S. Agarwal, P. Kumar, A. Son, M. Ko, E. Gallo, S. Fisher, A. Di Rocco, M. Biagioni (New York, NY, USA)

    Objective: To explore the feasibility of pairing repetitive transcranial magnetic stimulation (rTMS) back-to-back with standard of care physical therapy (PT) for posture instability and gait…
  • 2017 International Congress

    Determinant factors of treatment adherence in Parkinson’s disease

    I. Estrada-Bellmann, C. Cerda-Contreras, J. Peña-Avendaño, D. Ortiz-Zacarías, P. Cortés-Estrada (Monterrey, Mexico)

    Objective: To determine factors predicting treatment adherence in patients with idiopathic Parkinson’s disease. Background: Parkinson’s disease is the second most common cause of neurodegenerative disease…
  • 2017 International Congress

    Closed Loop STN DBS for Tremor in Parkinson’s disease using a Neural or Kinematic Signal

    A. Velisar, J. Herron, J. SYRKIN-NIKOLAU, Z. Blumenfeld, M. TRAGER, T. MARTIN, H. CHIZECK, H. Bronte-Stewart (Palo Alto, CA, USA)

    Objective: Compare safety, tolerability, efficiency and efficacy of closed loop DBS (clDBS) of the subthalamic nucleus (STN) for resting tremor in Parkinson’s disease (PD) using…
  • 2017 International Congress

    Comparison of neurotoxic potency of a newly produced Botulinum Neurotoxin Type A with onabotulinumtoxinA, incobotulinumtoxinA and BotulinumtoxinA

    Y. Feng, W. Liu, L. Pan, Z. Nie (Shanghai, China)

    Objective: This study aims to compare the neurotoxic potency of four different kinds of toxins, accompanied with expression level changes of key factors after BoNT/A…
  • 2017 International Congress

    The therapeutic effects of cortical electrical stimulation in an animal model of Parkinson’s disease

    T.-H. Hsieh, W.-S. Chang Chien, C.-W. Peng, Y.-Z. Hunag, J.-J. Chen (Taoyuan, Taiwan)

    Objective: In this study, we first designed the long-term implantable cortical electrical stimulation (CES) module in a rat model of Parkinson's disease (PD). With the…
  • 2017 International Congress

    Intrajejunal levodopa infusion (ILI) for Parkinson’s Disease (PD): A Canadian Experience

    P. Podgorny, P. McCann, K. Toore, G. Tremain, A. Lazarescu, O. Suchowersky (Edmonton, AB, Canada)

    Objective: To review the benefits and complications of ILI for PD in a tertiary movement disorders center in Canada. Background: ILI has been in use…
  • 2017 International Congress

    Protocol for upper-limb kinematic analysis in paediatric movement disorders and relative normality data

    L. Garavaglia, E. Pagliano, A. Lo Mauro, G. Baranello, A. Aliverti, S. Pittaccio (Lecco, Italy)

    Objective: The study proposes a specialised protocol to collect and analyse kinematic data from paediatric patients affected by Movement Disorders (MD). The aim is to…
  • 2017 International Congress

    More effective rTMS site for the freezing of gait in Parkinson’s disease

    S.Y. Kang, S.J. Kim (Hwaseong, Republic of Korea)

    Objective: The aim of study is to find brain stimulation areas showing more effective response. Background: Freezing of gait (FOG) is frustrating problem in Parkinson’s…
  • 2017 International Congress

    Design of a randomized, sham-controlled trial of pallidal neurostimulation versus botulinum toxin treatment for cervical dystonia (StimTox-CD)

    H. Drechsel, U. Malzahn, C. Roeser, P. Heuschmann, J. Volkmann (Würzburg, Germany)

    Objective: In this trial we will assess the efficacy and safety of pallidal deep brain stimulation (DBS) versus botulinum toxin A (BoNT A) therapy in cervical…
  • « Previous Page
  • 1
  • …
  • 1649
  • 1650
  • 1651
  • 1652
  • 1653
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley